126 related articles for article (PubMed ID: 33554262)
21. Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.
Liang Q; Chopra P; Boons GJ; Sharp JS
Carbohydr Res; 2018 Jul; 465():16-21. PubMed ID: 29920400
[TBL] [Abstract][Full Text] [Related]
22. Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains.
Hovingh P; Piepkorn M; Linker A
Eur J Biochem; 1993 Feb; 211(3):771-9. PubMed ID: 8436134
[TBL] [Abstract][Full Text] [Related]
23. Heparin-like heparan sulfate from rabbit cartilage.
Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
[TBL] [Abstract][Full Text] [Related]
24. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.
Kuberan B; Lech M; Zhang L; Wu ZL; Beeler DL; Rosenberg RD
J Am Chem Soc; 2002 Jul; 124(29):8707-18. PubMed ID: 12121115
[TBL] [Abstract][Full Text] [Related]
25. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.
Gao W; Xu Y; Liu J; Ho M
Sci Rep; 2016 May; 6():26245. PubMed ID: 27185050
[TBL] [Abstract][Full Text] [Related]
27. Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides having a Domain Structure.
Sun L; Chopra P; Boons GJ
Angew Chem Int Ed Engl; 2022 Nov; 61(47):e202211112. PubMed ID: 36148891
[TBL] [Abstract][Full Text] [Related]
28. Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization.
Brown S; Kuberan B
Methods Mol Biol; 2015; 1229():21-9. PubMed ID: 25325940
[TBL] [Abstract][Full Text] [Related]
29. Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.
Cole CL; Hansen SU; Baráth M; Rushton G; Gardiner JM; Avizienyte E; Jayson GC
PLoS One; 2010 Jul; 5(7):e11644. PubMed ID: 20657775
[TBL] [Abstract][Full Text] [Related]
30. Generating heparan sulfate saccharide libraries for glycomics applications.
Powell AK; Ahmed YA; Yates EA; Turnbull JE
Nat Protoc; 2010 May; 5(5):821-33. PubMed ID: 20379137
[TBL] [Abstract][Full Text] [Related]
31. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional characterization of the interaction between cyclophilin B and a heparin-derived oligosaccharide.
Hanoulle X; Melchior A; Sibille N; Parent B; Denys A; Wieruszeski JM; Horvath D; Allain F; Lippens G; Landrieu I
J Biol Chem; 2007 Nov; 282(47):34148-58. PubMed ID: 17855358
[TBL] [Abstract][Full Text] [Related]
33. HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity.
Seffouh A; Milz F; Przybylski C; Laguri C; Oosterhof A; Bourcier S; Sadir R; Dutkowski E; Daniel R; van Kuppevelt TH; Dierks T; Lortat-Jacob H; Vivès RR
FASEB J; 2013 Jun; 27(6):2431-9. PubMed ID: 23457216
[TBL] [Abstract][Full Text] [Related]
34. Glycomics profiling of heparan sulfate structure and activity.
Turnbull JE; Miller RL; Ahmed Y; Puvirajesinghe TM; Guimond SE
Methods Enzymol; 2010; 480():65-85. PubMed ID: 20816205
[TBL] [Abstract][Full Text] [Related]
35. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
[TBL] [Abstract][Full Text] [Related]
36. Resolving Heparan Sulfate Oligosaccharide Positional Isomers Using Hydrophilic Interaction Liquid Chromatography-Cyclic Ion Mobility Mass Spectrometry.
Cavallero GJ; Zaia J
Anal Chem; 2022 Feb; 94(5):2366-2374. PubMed ID: 35090117
[TBL] [Abstract][Full Text] [Related]
37. Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.
ten Dam GB; van de Westerlo EM; Smetsers TF; Willemse M; van Muijen GN; Merry CL; Gallagher JT; Kim YS; van Kuppevelt TH
J Biol Chem; 2004 Sep; 279(37):38346-52. PubMed ID: 15247295
[TBL] [Abstract][Full Text] [Related]
38. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells.
Zhang L; Yoshida K; Liu J; Rosenberg RD
J Biol Chem; 1999 Feb; 274(9):5681-91. PubMed ID: 10026187
[TBL] [Abstract][Full Text] [Related]
39. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.
Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J
PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119
[TBL] [Abstract][Full Text] [Related]
40. Identification of an MIP-1alpha -binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs.
Stringer SE; Nelson MS; Gupta P
Blood; 2003 Mar; 101(6):2243-5. PubMed ID: 12406885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
